| Stage | KRYS | % of rev | AMGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $127M | 100.00% | $10.4B | 100.00% | AMGN ×81.40 |
| Gross profit | $120M | 94.07% | $7.6B | 73.10% | KRYS +21.0pp |
| Operating income | $71M | 55.87% | $3.7B | 35.79% | KRYS +20.1pp |
| Pre-tax income | $80M | 62.94% | $4.7B | 45.21% | KRYS +17.7pp |
| Net income | $63M | 49.53% | $3.9B | 37.28% | KRYS +12.2pp |
| Stage | KRYS | AMGN | Gap · A − B |
|---|---|---|---|
| Revenue | $127M100.00% | $10.4B100.00% | AMGN ×81.40 |
| Gross profit | 94.07%$120M | 73.10%$7.6B | KRYS +21.0pp |
| Operating income | 55.87%$71M | 35.79%$3.7B | KRYS +20.1pp |
| Pre-tax income | 62.94%$80M | 45.21%$4.7B | KRYS +17.7pp |
| Net income |
| 49.53%$63M |
| 37.28%$3.9B |
| KRYS +12.2pp |
No shared counterparties.